Population pharmacokinetics of high-dose methotrexate administered in 329 children with acute lymphoblastic leukemia
Chun-Yan ZHANG; Jian GU; Yu-Zhen LI; Wei LU.
Journal of Experimental Hematology
; (6): 106-110, 2008.
ArtÃculo en Zh | WPRIM | ID: wpr-253371
Documentos relacionados
Low-dimensional neural ODEs and their application in pharmacokinetics.
Assessment of the nlmixr R package for population pharmacokinetic modeling: A metformin case study.
Training the next generation of pharmacometric modelers: a multisector perspective.
Machine Learning Models for Human <i>In Vivo</i> Pharmacokinetic Parameters with In-House Validation.
Application of physiologically based pharmacokinetic models for therapeutic proteins and other novel modalities.
Development of a genetic algorithm and NONMEM workbench for automating and improving population pharmacokinetic/pharmacodynamic model selection.
The Finite Absorption Time (FAT) concept en route to PBPK modeling and pharmacometrics.
Determination of the Number of Tissue Groups of Kinetically Distinct Transit Time in Whole-Body Physiologically Based Pharmacokinetic (PBPK) Models I: Theoretical Consideration of Bottom-Up Approach of Lumping Tissues in Whole-Body PBPK.
Application of machine learning techniques in population pharmacokinetics/pharmacodynamics modeling.
An Analytical Solution for Saturable Absorption in Pharmacokinetics Models.